These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35449346)

  • 1. Analysis of the frequency of ceftriaxone-induced encephalopathy using the Japanese Adverse Drug Event Report database.
    Yamada T; Mitsuboshi S; Suzuki K; Nishihara M; Neo M
    Int J Clin Pharm; 2022 Aug; 44(4):1067-1071. PubMed ID: 35449346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.
    Suzuki S; Naito S; Numasawa Y; Asada M; Shoji N; Zeniya M; Takahashi D; Sato H; Iimori S; Nomura N; Sohara E; Okado T; Ishiwata Y; Nagata M; Rai T; Yokota T; Uchida S
    Intern Med; 2019 Jun; 58(12):1775-1779. PubMed ID: 30799339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients.
    Onogi C; Osada A; Imai K; Mimura T; Saka Y; Urahama Y; Oishi H; Naruse T
    Hemodial Int; 2022 Jul; 26(3):E27-E30. PubMed ID: 35441472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.
    Hagiya H; Miyawaki K; Yamamoto N; Yoshida H; Kitagawa A; Asaoka T; Eguchi H; Akeda Y; Tomono K
    Intern Med; 2017 Nov; 56(22):3103-3107. PubMed ID: 28943562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid.
    Nishioka H; Cho Y; Irie K; Kanamori M
    Int J Infect Dis; 2022 Mar; 116():223-225. PubMed ID: 35063677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection.
    Roncon-Albuquerque R; Pires I; Martins R; Real R; Sousa G; von Hafe P
    Neth J Med; 2009 Feb; 67(2):72-5. PubMed ID: 19299850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre.
    Shalviri G; Yousefian S; Gholami K
    J Clin Pharm Ther; 2012 Aug; 37(4):448-51. PubMed ID: 22122488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological and hepatic adverse effects of ceftriaxone in ambulatory care: a dual-centre retrospective observational analysis of standard vs high dose.
    Mistry R; Rawson TM; Troise O; Mughal N; Moore LSP; Hughes S
    BMC Infect Dis; 2022 Dec; 22(1):959. PubMed ID: 36566229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report.
    Muniandy G; Kamaruzaman L; Jan TH; Mohd R; Neesam MT; Fong Voon K; Pau Kiew B; Mustafar R
    Acta Med Indones; 2023 Jan; 55(1):78-82. PubMed ID: 36999269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of haematological events and preventive effect of folic acid in methotrexate users with chronic kidney disease and rheumatoid arthritis: Analysis of the Japanese Adverse Drug Event Report database.
    Mitsuboshi S
    Br J Clin Pharmacol; 2021 May; 87(5):2286-2289. PubMed ID: 33179261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database.
    Mitsuboshi S; Niimura T; Aizawa F; Goda M; Zamami Y; Ishizawa K
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):553-556. PubMed ID: 35174631
    [No Abstract]   [Full Text] [Related]  

  • 13. Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database.
    Lacroix C; Kheloufi F; Montastruc F; Bennis Y; Pizzoglio V; Micallef J
    J Neurol Sci; 2019 Mar; 398():196-201. PubMed ID: 30683462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
    Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
    J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score.
    Nakaharai K; Sakamoto Y; Yaita K; Yoshimura Y; Igarashi S; Tachikawa N
    Eur J Clin Pharmacol; 2016 Aug; 72(8):1003-11. PubMed ID: 27126206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalopathy induced by high levels of ceftriaxone in the blood and cerebrospinal fluid.
    Minamii T; Shimizu H; Irie K; Nishioka H
    IDCases; 2022; 29():e01581. PubMed ID: 35938149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.
    Imafuku A; Sawa N; Sekine A; Kawada M; Hiramatsu R; Yamanouchi M; Hasegawa E; Hayami N; Hoshino J; Ubara Y; Takaichi K
    Clin Exp Nephrol; 2018 Jun; 22(3):613-619. PubMed ID: 29027036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic therapy for adults with neurosyphilis.
    Buitrago-Garcia D; Martí-Carvajal AJ; Jimenez A; Conterno LO; Pardo R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD011399. PubMed ID: 31132142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor-associated aortitis in the Japanese Adverse Drug Event Report database.
    Oshima Y; Takahashi S; Tani K; Tojo A
    Cytokine; 2019 Jul; 119():47-51. PubMed ID: 30875590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
    Chisaki Y; Aoji S; Yano Y
    Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.